Skip to content

Collegium Pharmaceutical, Inc. COLL Accrued Income Taxes, Current

Accrued Income Taxes, Current at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$26M+117%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$100K-85.7%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$5.29M-9.7%
Organon logo
OrganonOGN
$77M-56.3%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s accrued income taxes, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s accrued income taxes, current?
Collegium Pharmaceutical, Inc. (COLL) reported accrued income taxes, current of $7.8M in Q1 2026.
What does accrued income taxes, current mean?
This represents the estimated amount of income tax payable to government authorities for the current period. It reflects the company's tax liability based on taxable income generated during the year, which is due within the next twelve months. It is a key indicator of the company's immediate tax obligations.